If Trump indeed tanks your 401(k) to make himself and his friends even richer, the opposition party should make that the centerpiece of their attack heading into next year’s election.
PhRMA
Follow:
-
Martin Shkreli Is An Example Of Why We Need Publicly Funded Pharmaceutical Research
Facing national outrage, the 32-year-old CEO backed down from the 5000% price increase his company announced this week for the malaria and toxoplasmosis drug Daraprim, sparking an overdue debate about the outlandish cost of life-saving medicines.